Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Opioid-Induced Constipation 8Neoplasms 3Constipation 2Pain 1Cancer Pain 1

Interventions

alvimopan 3Ketamine 2oxycodone naloxone combination 1naloxegol 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Radiotherapy 1Quality of Life 1Oxycodone 1Nicotine 1Neck Dissection 1Naloxone 1Mindfulness-Based Stress Reduction 1Lidocaine 1Injections 1Gelclair 1Fibroblast Growth Factor 7 1Exercise Movement Techniques 1Doxepin 1Diphenhydramine 1Cisplatin 1Betaine 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × naloxegol × Other × Clear all
NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated
12 enrolled 33 charts
Other

Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡